Estrogen replacement therapy use in minority postmenopausal women

Ethnicity and Disease

Volumn 10, Issue 2, 2000, Pages 257-261

  Ganesan, Kalpana ^a,b,c   Teklehaimanot, Senait ^b   Norris, Keith ^b,c  

^a KING DREW MEDICAL CENTER   (United States)

^b Charles R Dew University of Medicine and Science   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African American; Estrogen Replacement Therapy; Hispanic; Women

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; ATTITUDE TO HEALTH; ESTROGEN THERAPY; FEMALE; HISPANIC; HUMAN; MALE; MIDDLE AGED; UTILIZATION REVIEW;

AFRICAN AMERICANS; AGED; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED;

EID: 0034153355     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
2. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health. 1998; 19:55-72.
3. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998;90(11):4-823.
4. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975;293:1167-1170.
5. US Department of Health and Human Services. Mortality, part B. In: Vital Statistics of the United States: Various Years Through 1991. Hyattsville, Md: National Center for Health Statistics; 1995:2.
6. Riggs BL. Pathogenesis of osteoporosis. Am J Obstet Gynecol. 1987;156:1342-1346.
7. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal therapy and coronary artery disease. N Eng J Med. 1985;313:1044-1049.
8. Stampfer MJ, Colditez GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten year follow-up from the Nurses' Health Study. N Engl J Med. 1991;725:756-762.
9. The writing group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) Trial. JAMA. 1996;276:1389-1396.
10. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke established populations for the epidemiologic studies of the elderly (EPESE). J Am Geriatr Soc. 1996;44:1-6.
11. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438-1444.
12. Hahn RG, Nachtigall RD, Davies TC. Compliance difficulties with progestin-supplemented estrogen replacement therapy. J Fam Pract. 1984;18:411-414.
13. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: a survey of older women's attitudes. Arch Intern Med. 1996;156:1293-1297.
14. McNagny SE, Jacobson TA. Use of postmenopausal hormone replacement therapy by African-American women. The importance of physician discussion. Arch Intern Med. 1997;157:1337-1342.
15. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med. 1989;149: 133-136.
16. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Prev Med. 1988;17:403-411.
17. Stern MP, Brown BW, Haskell WL, Forquhar JW, Wehrle CL, Wood PD. Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. Stanford Three-Community Study. JAMA. 1976;235:811-815.
18. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol. 1988;128:606-614.
19. Johannes CB, Crawford SL, Posner JG, McKinlay SM. Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol. 1994;140:439-452.
20. Barrett-Connor E, Wegner NK, Grady D, et al. Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene. J Womens Health. 1998;7(7):839-847.
21. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336(25):1769-1775.